相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The genetic basis for most patients with pustular skin disease remains elusive
R. Mossner et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52-week, open-label study
K. Yamasaki et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis
C. Mugheddu et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Secukinumab for the Treatment of Deficiency of Interleukin 36 Receptor Antagonist in an Adolescent
Vered Molho-Pessach et al.
JAMA DERMATOLOGY (2017)
Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study
Shinichi Imafuku et al.
JOURNAL OF DERMATOLOGY (2016)
Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab
Alexander Boehner et al.
JAMA DERMATOLOGY (2016)
Therapeutic Efficacy of Interleukin 12/Interleukin 23 Blockade in Generalized Pustular Psoriasis Regardless of IL36RN Mutation Status
Akiko Arakawa et al.
JAMA DERMATOLOGY (2016)
IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis
Safia Hussain et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Successful treatment with infliximab of sibling cases with generalized pustular psoriasis caused by deficiency of interleukin-36 receptor antagonist
K. Sugiura et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis
H. Saeki et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Serum cytokines correlated with the disease severity of generalized pustular psoriasis
Masaaki Yamamoto et al.
DISEASE MARKERS (2013)
The Majority of Generalized Pustular Psoriasis without Psoriasis Vulgaris Is Caused by Deficiency of Interleukin-36 Receptor Antagonist
Kazumitsu Sugiura et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Mutations in IL36RN in Patients with Generalized Pustular Psoriasis
Andreas Koerber et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
分享论文
